About us
ABCDx is a company headquartered in Spain that discovers and develops diagnostic tools transforming care for patients with brain injuries. ABCDx’s devices help the healthcare professionals in the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury from stroke and trauma to post-injury complications and patient outcome.
ABCDx is pioneering the ability to decode the chemical messages of the brain (brain biomarkers).
So that brain injury can be detected in a drop of blood
from a finger prick, allowing the diagnosis at the admission of the emergency department, before hospitalization or even directly on the field where the injury occurred.
About the founders
Prof. Sanchez
Prof. Sanchez & Dr Montaner Villalonga are recognized as Key Opinion Leaders in the field of brain biomarkers. They combine their unique expertise in brain biomarker discovery, awareness and clinical validation.
Their continuous discoveries of novel brain biomarkers constitute the IP portfolio of ABCDx and allow a rapid access to clinical validation for ABCDx’s medical devices.
Prof. Sanchez & Dr Montaner Villalonga are recognized as Key Opinion Leaders in the field of brain biomarkers. They combine their unique expertise in brain biomarker discovery, awareness and clinical validation.
Their continuous discoveries of novel brain biomarkers constitute the IP portfolio of ABCDx and allow a rapid access to clinical validation for ABCDx’s medical devices.